tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Julie Mead, 4 are a HOLD (80%), 1 are a SELL (20%).
Analyst Julie Mead, currently employed at HSBC, carries an average stock price target met ratio of 50% that have a potential upside of 3.32% achieved within 4 days.
Julie Mead’s has documented 8 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 17-Oct-2021.
Analyst best performing recommendations are on AZN (ASTRAZENECA PLC ADR).
The best stock recommendation documented was for AZN (ASTRAZENECA PLC ADR) at 11/11/2020. The price target of $95.67 was fulfilled within 7 days with a profit of $6.79 (6.63%) receiving and performance score of 9.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Apr-2019
$105
$-83.42 (-44.27%)
$95
3 months 23 days ago
(09-Dec-2025)
0/13 (0%)
$-72.77 (-40.93%)
Buy Since 05-Sep-2023
$108.5
$-79.92 (-42.42%)
$91.7
4 months 7 days ago
(25-Nov-2025)
1/6 (16.67%)
$-76.04 (-41.21%)
483
Buy Since 13-Feb-2025
$4925
5 months 5 days ago
(27-Oct-2025)
8/9 (88.89%)
$4764.49 (2968.34%)
170
Hold Since 06-Nov-2024
1 years 1 months 20 days ago
(12-Feb-2025)
12/12 (100%)
$29.07 (22.44%)
713
Buy Since 29-Sep-2020
1 years 4 months 12 days ago
(20-Nov-2024)
4/5 (80%)
$28.41 (23.34%)
709
What Year was the first public recommendation made by Julie Mead?
